CIRS - The Centre for Innovation in Regulatory Science

Home
Member Login
Contact Us

The Centre for Innovation in Regulatory Science (CIRS) is a neutral, independent organisation conducting novel research, convening international forums for healthcare stakeholders and providing science-based insights to advance global regulatory and HTA policies and enhance patient access to medicines.

CIRS: The Centre for Innovation in Regulatory Science

About Us
Global Development Programme
HTA and Market Access Programme
OpERA
Workshops
- Past Workshops
- Upcoming Workshops
Publications
Decision Making
- Tools
  - CIRS-BRAT Framework
  - UMBRA Initiative

Slide of the Month

January 2019 Slide of the month

Regional regulatory initiatives streamline the regulatory review process.

Slide of the Month Archive >

CIRS NEWS

CIRS Senior Research Analyst Magda Bujar wins Margaret K B Day Prize

CONTACT US

Search our site

MEMBER LOGIN

Members have access to:
• Past Workshop Slides
• Atlas
and much more.
Login to our CIRS Member’s Section

CIRS 2019 AGENDA

Download the CIRS 2019 Agenda

Where to meet us

15-19 June 2019; HTAi, Cologne, Germany
23-27 June 2019; DIA, San Diego, CA
2-6 November 2019 ISPOR, Copenhagen, Denmark

READ

Our most recent publications

R&D Briefing 69: Review of HTA outcomes and timelines in Australia, Canada and Europe 2014-2017

Bujar M, McAuslane N, Walker S, Salek S. The reliability and relevance of a quality of decision- making instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for use during the lifecycle of medicines. Front Pharmacol. 2019;10:17. Published 2019 Jan 23. doi:10.3389/fphar.2019.00017

Keyter A, Banoo S, Salek S, Walker S. The South African regulatory system: past, present and future. Front Pharmacol. 2018; 9: published online 4 December.

Liberti L. The practical application of regulatory science: Impact on regulatory policy and practice. Reg Rapporteur. 2018; 15:3-5-9.

Mashaki Ceyhan E, Gürsöz H, Alkan A, Coşkun H, Koyuncu O, Walker S. The Turkish Medicines and Medical Devices Agency: Comparison of its registration process with Australia, Canada, Saudi Arabia, and Singapore. Front Pharmacol. 2018;9 DOI=10.3389/fphar.2018.

more

© CIRS: The Centre for Innovation in Regulatory Science 2019

Centre for Innovation in Regulatory Science